SANA$2.397.20%-0.185
After Hours: 2.39+0.01 +0.21%
Sana Biotechnology Inc (SANA)
Date: 2026-11-02 16:00O: 2.57H: 2.59L: 2.37C: 2.39Vol: 2.253M
Sana Biotechnology Inc stock is traded at $2.39, with a volume of 2,253,461. It is down -7.20% in the last 24 hours and down -17.47% over the past month. Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Previous Close:
$2.57
Open:
$2.57
24h Volume:
2,253,461
Relative Volume:
0.88
Market Cap:
$713.98M
Revenue:
-
Net Income/Loss:
-$241.99M
P/E Ratio:
-
EPS:
-$0.9389
Net Cash Flow:
-$133.64M
1W Performance:
+1.06%
1M Performance:
-17.47%
6M Performance:
-27.06%
1Y Performance:
-51.82%
1-Day Range:
$2.37$2.59
1-Week Range:
$2.37$2.77
52-Week Range:
$2.22$5.49
Sana Biotechnology Inc Stock (SANA) Company Profile
Name
Sana Biotechnology IncSector
HealthcareIndustry
BiotechnologyPhone
(206) 701-7914Address
188 EAST BLAINE STREET, SUITE 350, SEATTLE, USACompare SANA vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
SANA Sana Biotechnology Inc | $713.98M | $0 | -$211.82M | -$135.06M | -$0.9389 |
 VRTX Vertex Pharmaceuticals Inc | $140.94B | $12.59B | $4.41B | $3.80B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $99.46B | $16.90B | $4.82B | $3.83B | $41.04 |
 MRNA Moderna Inc | $88.17B | $2.23B | -$3.15B | -$1.24B | -$8.15 |
 ARGX Argen X Se Adr | $55.03B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $40.86B | $6.13B | $655.71M | $1.33B | $4.48 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
Sana Biotechnology Inc Stock (SANA) Financials Data
Sana Biotechnology Inc Stock (SANA) Insider Trading
- PATEL DHAVALKUMAR DHIRAJLALAug 26 '26EVP, Chief Scientific Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 125,000
- Value ($)
- 0
- #Shares Total
- 224,510
- Wyrick Susan D.Mar 07 '26See Remarks
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 3,250
- Value ($)
- 0
- #Shares Total
- 200,583
- Harr SteveMar 07 '26President & CEO
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 50,000
- Value ($)
- 0
- #Shares Total
- 7,968,596
- Wyrick Susan D.Mar 06 '26See Remarks
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 10,416
- Value ($)
- 0
- #Shares Total
- 197,333
- Harr SteveMar 06 '26President & CEO
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 41,666
- Value ($)
- 0
- #Shares Total
- 7,918,596
- Wyrick Susan D.Mar 02 '26See Remarks
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,525
- Value ($)
- 0
- #Shares Total
- 187,408
- Wyrick Susan D.Jan 02 '26See Remarks
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 7,500
- Value ($)
- 0
- #Shares Total
- 188,290
- Wyrick Susan D.Dec 13 '25See Remarks
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 3,400
- Value ($)
- 0
- #Shares Total
- 181,663
- Wyrick Susan D.Dec 03 '25See Remarks
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 10,000
- Value ($)
- 0
- #Shares Total
- 180,828
